Finance

Lists
AGN:ASX
Argenica Therapeutics Ltd
A$0.12
0.00%
(0.00) 1D
Oct 19, 12:16:18 PM GMT+11  ·   AUD
All symbols
SymbolPriceChange% Change
Generating top insights for AGN...
Mkt. cap
15.41M
Avg. vol.
53.14K
Volume
0.00
52-wk high
A$0.34
52-wk low
A$0.09
EPS
-A$0.01
Shares outstanding
128.46M
Mkt. cap
15.41M
Avg. vol.
53.14K
Volume
0.00
52-wk high
A$0.34
52-wk low
A$0.09
EPS
-A$0.01
Shares outstanding
128.46M
News stories
From web sources and news partners
About Argenica Therapeutics Ltd
CEO-
Employees-
Founded2019
Headquarters-
SectorPharmaceutical industry
Websiteargenica.com.au
Last report
Jul 24, 2026
Fiscal period
Q4 2026
- / -
Revenue / Est. (AUD)
2.43M / -
Fiscal Q4 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in AUD
Loading Previous Earnings...
Revenue
Net income
All values in AUD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
313.37K
313.37K
2.43M
2.43M
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
1.52M
1.52M
588.41K
588.41K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
739.40K
739.40K
643.55K
643.55K
Operating expense
2.27M
2.27M
1.26M
1.26M
Total operating expenses
2.27M
2.27M
1.26M
1.26M
Operating income
-1.96M
-1.96M
1.17M
1.17M
Other non operating income
-
-
-
-
EBT including unusual items
-1.91M
-1.91M
1.23M
1.23M
EBT excluding unusual items
-1.91M
-1.91M
1.23M
1.23M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
26.46K
26.46K
Net income
-1.91M
-1.91M
1.23M
1.23M
Net profit margin
-609.00%
-609.00%
50.46%
50.46%
Earnings per share
-
-
-
-
Interest and investment income
46.72K
46.72K
59.29K
59.29K
Interest expense
-94.00
-94.00
-63.00
-63.00
Net interest expenses
46.62K
46.62K
59.23K
59.23K
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps